MULTICENTER PHASE-II TRIAL OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

被引：38
|
作者：
URBA, S
DOROSHOW, J
CRIPPS, C
ROBERT, F
VELEZGARCIA, E
DALLAIRE, B
ADAMS, D
CARLSON, R
GRILLOLOPEZ, A
GYVES, J
机构：
[1] CITY HOPE NATL MED CTR,DUARTE,CA 91010
[2] OTTAWA REG CANC CTR,OTTAWA,ONTARIO,CANADA
[3] SAN JUAN VET HOSP,SAN JUAN,PR
[4] DUPONT PHARMACEUT CO,WILMINGTON,DE
[5] UNIV PUERTO RICO,SCH MED,SAN JUAN,PR 00936
[6] UNIV MICHIGAN,ANN ARBOR,MI 48109
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1992年 / 31卷 / 02期
关键词：
D O I：
10.1007/BF00685106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A total of 19 patients with advanced squamous-cell carcinoma of the head and neck who had not previously been exposed to chemotherapy were treated with brequinar sodium as first-line chemotherapy. Brequinar was given intravenously at a median weekly dose of 1,200 mg/m2. The toxicity was moderate, with 7 patients (37%) experiencing grade 3 or 4 toxicity. In all, 16 patients who were evaluable for efficacy showed no objective response. We conclude that brequinar given at this dose and on this schedule has no significant activity in advanced squamous-cell carcinoma of the head and neck.
引用
收藏
页码：167 / 169
页数：3
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF MITOGUAZONE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    PERRY, DJ
    CRAIN, SM
    WELTZ, MD
    WILSON, JP
    DAVIS, RK
    WOOLLEY, PV
    FORASTIERE, AA
    TAYLOR, HG
    WEISS, RB
    CANCER TREATMENT REPORTS, 1983, 67 (01): : 91 - 92
  • [2] A PHASE-II TRIAL OF ACLACINOMYCIN-A IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    ECKENRODE, JL
    WHEELER, RH
    FORASTIERE, AA
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (04) : 389 - 392
  • [3] PHASE-II TRIAL OF CARBOPLATIN AND VINBLASTINE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    ELSAYED, S
    SYMONDS, RP
    ROBERTSON, AG
    PAUL, J
    MCGARVA, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (06) : 464 - 466
  • [4] A PHASE-II STUDY OF PIRITREXIM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    DEGARDIN, M
    DOMENGE, C
    CAPPELAERE, P
    LUBOINSKI, B
    NAVARRETE, MS
    SCOTT, JE
    LEFEBVRE, JL
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (07) : 1044 - 1045
  • [5] TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH ISOTRETINOIN - A PHASE-II RANDOMIZED TRIAL
    LIPPMAN, SM
    KESSLER, JF
    ALSARRAF, M
    ALBERTS, DS
    ITRI, LM
    MATTOX, D
    VONHOFF, DD
    LOESCHER, L
    MEYSKENS, FL
    INVESTIGATIONAL NEW DRUGS, 1988, 6 (01) : 51 - 56
  • [6] MULTICENTER PHASE-II TRIAL OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED MELANOMA
    NATALE, R
    WHEELER, R
    MOORE, M
    DALLAIRE, B
    LYNCH, W
    CARLSON, R
    GRILLOLOPEZ, A
    GYVES, J
    ANNALS OF ONCOLOGY, 1992, 3 (08) : 659 - 660
  • [7] PHASE-II TRIAL OF IPROPLATIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, ESOPHAGUS AND LUNG
    CAPPELAERE, P
    GUIOCHET, N
    BASTIT, P
    FAVRE, R
    VANDERBURG, M
    GOUPIL, A
    CHAUVERGNE, J
    THOMAS, D
    VANGLABBEKE, M
    ARMAND, JP
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (08) : 1216 - 1216
  • [8] PHASE-II TRIAL OF VINDESINE IN ADVANCED SQUAMOUS-CELL CANCER OF THE HEAD AND NECK
    VOGL, SE
    CAMACHO, FJ
    KAPLAN, BH
    ODONNELL, MR
    CANCER TREATMENT REPORTS, 1984, 68 (03): : 559 - 560
  • [9] PHASE-II STUDY OF DOXIFLURIDINE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    ABELE, R
    KAPLAN, E
    GROSSENBACHER, R
    SCHMID, HJ
    CAVALLI, F
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (03): : 333 - 336
  • [10] PHASE-II TRIAL OF TIAZOFURIN IN RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    DIMERY, IW
    NEIDHART, JA
    MCCARTHY, K
    KRAKOFF, IH
    HONG, WK
    CANCER TREATMENT REPORTS, 1987, 71 (04): : 425 - 426
12345